Concepts (76)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stroke | 7 | 2017 | 259 | 1.020 |
Why?
|
| Fibrinolytic Agents | 6 | 2016 | 53 | 0.870 |
Why?
|
| Tissue Plasminogen Activator | 6 | 2016 | 39 | 0.810 |
Why?
|
| Remote Consultation | 2 | 2016 | 11 | 0.640 |
Why?
|
| Subarachnoid Hemorrhage | 4 | 2016 | 32 | 0.470 |
Why?
|
| Cerebral Hemorrhage | 3 | 2020 | 104 | 0.380 |
Why?
|
| Thrombolytic Therapy | 5 | 2016 | 48 | 0.370 |
Why?
|
| Hospital Mortality | 3 | 2016 | 131 | 0.350 |
Why?
|
| Infarction, Middle Cerebral Artery | 4 | 2014 | 9 | 0.340 |
Why?
|
| Thrombectomy | 2 | 2017 | 30 | 0.260 |
Why?
|
| Severity of Illness Index | 3 | 2016 | 913 | 0.210 |
Why?
|
| beta-Alanine | 2 | 2012 | 3 | 0.200 |
Why?
|
| Benzimidazoles | 2 | 2012 | 8 | 0.200 |
Why?
|
| Anticoagulants | 2 | 2012 | 88 | 0.190 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 24 | 0.190 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2016 | 1084 | 0.170 |
Why?
|
| Atrial Fibrillation | 2 | 2012 | 120 | 0.170 |
Why?
|
| Brain Ischemia | 1 | 2020 | 58 | 0.170 |
Why?
|
| Time Factors | 4 | 2016 | 1336 | 0.160 |
Why?
|
| Middle Aged | 10 | 2017 | 8403 | 0.160 |
Why?
|
| Aged | 10 | 2017 | 8501 | 0.160 |
Why?
|
| Female | 13 | 2021 | 14273 | 0.160 |
Why?
|
| Acute Disease | 2 | 2016 | 187 | 0.150 |
Why?
|
| Male | 12 | 2017 | 13917 | 0.150 |
Why?
|
| Humans | 17 | 2021 | 25692 | 0.150 |
Why?
|
| International Normalized Ratio | 2 | 2014 | 18 | 0.140 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2017 | 11 | 0.140 |
Why?
|
| Patient Transfer | 1 | 2017 | 22 | 0.140 |
Why?
|
| Informed Consent | 1 | 2015 | 21 | 0.120 |
Why?
|
| Socioeconomic Factors | 1 | 2016 | 277 | 0.120 |
Why?
|
| Cerebral Infarction | 1 | 2016 | 142 | 0.120 |
Why?
|
| Renal Dialysis | 1 | 2015 | 115 | 0.120 |
Why?
|
| Reperfusion | 1 | 2014 | 7 | 0.110 |
Why?
|
| Kidney Failure, Chronic | 1 | 2015 | 148 | 0.110 |
Why?
|
| Neoplasms | 1 | 2016 | 224 | 0.110 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 1 | 2013 | 4 | 0.110 |
Why?
|
| Brain Edema | 1 | 2013 | 19 | 0.110 |
Why?
|
| Encephalocele | 1 | 2013 | 20 | 0.110 |
Why?
|
| Intracranial Hypertension | 1 | 2013 | 14 | 0.100 |
Why?
|
| Vasospasm, Intracranial | 1 | 2012 | 5 | 0.100 |
Why?
|
| Aged, 80 and over | 6 | 2017 | 4459 | 0.100 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2020 | 84 | 0.070 |
Why?
|
| Retrospective Studies | 4 | 2017 | 3220 | 0.070 |
Why?
|
| Treatment Outcome | 4 | 2017 | 3231 | 0.070 |
Why?
|
| Risk Factors | 3 | 2016 | 2224 | 0.060 |
Why?
|
| Predictive Value of Tests | 2 | 2017 | 443 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2020 | 1633 | 0.050 |
Why?
|
| Adult | 4 | 2016 | 7336 | 0.050 |
Why?
|
| Young Adult | 2 | 2016 | 1855 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2014 | 698 | 0.040 |
Why?
|
| False Positive Reactions | 1 | 2017 | 26 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 2016 | 119 | 0.030 |
Why?
|
| Administration, Intravenous | 1 | 2015 | 21 | 0.030 |
Why?
|
| Adolescent | 1 | 2021 | 2076 | 0.030 |
Why?
|
| Ischemic Attack, Transient | 1 | 2015 | 18 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2016 | 252 | 0.030 |
Why?
|
| Fibrinogen | 1 | 2014 | 21 | 0.030 |
Why?
|
| Blood Coagulation Factors | 1 | 2014 | 19 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2014 | 60 | 0.030 |
Why?
|
| Triage | 1 | 2014 | 18 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2014 | 28 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2014 | 51 | 0.030 |
Why?
|
| Urban Population | 1 | 2014 | 149 | 0.030 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2012 | 5 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2012 | 55 | 0.030 |
Why?
|
| Cerebrovascular Circulation | 1 | 2012 | 32 | 0.030 |
Why?
|
| Partial Thromboplastin Time | 1 | 2012 | 4 | 0.030 |
Why?
|
| Platelet Count | 1 | 2012 | 14 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 1 | 2012 | 71 | 0.030 |
Why?
|
| Dabigatran | 1 | 2012 | 5 | 0.030 |
Why?
|
| Blood Coagulation | 1 | 2012 | 19 | 0.030 |
Why?
|
| ROC Curve | 1 | 2012 | 129 | 0.020 |
Why?
|
| Cerebral Angiography | 1 | 2012 | 31 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2014 | 618 | 0.020 |
Why?
|
| Brain | 1 | 2020 | 1560 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2012 | 1781 | 0.020 |
Why?
|